BLPH's INOPulse Misses Rhythm, ONCE Bleeds, FDA Panel Nod For INSM

Today's Daily Dose brings you news about FDA panel recommendation of Insmed's inhaled antibiotic; Bellerophon's disappointing INOpulse study results; mixed study results of Spark's investigational gene therapy SPK-8011 for hemophilia A, and FDA approval of Vertex Pharma's cystic fibrosis drug.

from RTT - Biotech https://ift.tt/2MsaDc2
via IFTTT